Navigation Links
Michael J. Fox Foundation Launches Rapid Response Innovation Awards 2008 Following Strong Inaugural Year Response
Date:12/12/2007

NEW YORK, Dec. 12 /PRNewswire-USNewswire/ -- Having funded $2 million total to support 27 high-risk, high-reward approaches to Parkinson's disease research in the first year of its Rapid Response Innovation Awards (RRIA) initiative, The Michael J. Fox Foundation today announced that it will commit $2 million to a second round of funding in 2008. RRIA is designed to ensure that researchers can pursue good ideas without delay. Under this program the Foundation accepts proposals on a rolling basis with no deadline, makes funding decisions within six weeks of application and speeds up to $75,000 to one-year basic, preclinical or clinical research projects in any Parkinson's-relevant arena.

"RRIA funds 'flashes of insight' in real time, hopefully helping to open new avenues for PD therapy development," said Katie Hood, interim CEO of The Michael J. Fox Foundation.

To accommodate these "flashes of insight," the program's criteria and application process are designed with novelty and speed in mind.

Todd Sherer, PhD, vice president of research programs at MJFF, said: "We set up RRIA to attract new researchers to Parkinson's and to provide support for unorthodox ideas -- the sort that could significantly impact PD treatment, but that may have little or no preliminary data, making it hard or impossible to find traditional funding to carry them out. Based on the strong response from the scientific community in 2007, it's clear this program is filling a need."

The program is designed to provide funding for strong ideas being tested for the first time. Unlike other Foundation initiatives, RRIA allows for the submission of applications at any time of year. There is no pre-proposal stage, and the standard application has been shortened to three pages. Additionally, postdoctoral researchers are permitted to apply as principal investigators under this initiative provided the head of their lab serves as Administrative PI to assist with the p
'/>"/>

SOURCE Michael J. Fox Foundation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Michael Moores SiCKO Becomes the Third Highest Grossing Documentary of All Time Surpassing An Inconvenient Truth
2. Katie Hood Appointed Interim Chief Executive Officer of Michael J. Fox Foundation
3. Clarient Names Michael J. Pellini, M.D. Chief Operating Officer
4. Digital Healthcare Announces Dr. Michael Fleming Joins Executive Team as Medical Director
5. Michael J. Fox Foundation Commits Up to $2 Million for PD Drug Development Under Target Validation 2008
6. BioElectronics Corporation Announces Addition of Michael Seidenman, R.Ph. as Vice President of Sales
7. BioSeek Appoints Michael C. Venuti, Ph.D., Chief Executive Officer
8. Irene Hegeman Richard, MD, Appointed Senior Medical Advisor to The Michael J. Fox Foundation
9. Actress Jenifer Lewis, Authors Dr. Michael Eric Dyson and Susan Taylor Among Featured Speakers for Senator Hughes Behavioral Mental Health Summit
10. National Patient Safety Foundation Partners with Vocera Communications
11. R. P. Simmons Family Foundation Pledges $2 Million for New Childrens Hospital of Pittsburgh of UPMC Campus

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)... Fans get a bigger thrill when on an emotional rol...v. 26 (HealthDay News) -- Call it the fear factor ...ggests that spectators -- especially those who roo...faction if it,s a closely contested match and vict...even despair. , Chew on that this Thanksgiving ...
(Date:11/26/2009)..., Research Triangle Denta...entral North Carolina, today announced the expansi...fied LUMINEER Dentist, Dr. Doug Macmillan. , ...rch Triangle Dental is pleased to announce that Dr...st, recently completed an additional advanced trai...
(Date:11/25/2009)...,, EDINA,Minn.,Nov.25/PRNewswire-USNewswire/...dentist.Butachiropractorcanalsogivepatientsthehelp...hichiswhereyourjaw(mandible)contacts/connectswithy...sassociatedwithTMJdysfunctionarepainwithchewing,cl...ausedfromTMJdysfunctionincluding:headaches,fatigue...
(Date:11/25/2009)...,, TORONTOandCALGARY,Nov.25/PRNewswire/-Sent...sonanceImaging(MRI)coilsandsoftwareandCalgaryScien...logies,haveintroducedawebversionofAegis(TM)Breast4...veinterfaceisthefirsttrulyzero-footprintWebclientb...tific,sPureWeb(TM)platformallowsforzero-footprinta...
(Date:11/25/2009)...,, SILVERSPRING,Md.,Nov.25/PRNewswire-USNews...FDA,sCenterforDrugEvaluationandResearch,titled"ADi...,"appearsintheNov.26,2009issueofTheNewEnglandJourn...cgi-bin/prnh/20090824/FDALOGO ) ,, Inthearticle...naccesstopainmedicationforthosewhoneeditandmanagin...
Breaking Medicine News(10 mins):Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3
...search Network is very near to achieving one of to...ge in the best possible health conditions.// ...nish universities of Seville, Oviedo, Saragossa, B...beings and present in many types of food – delays ...
...ev has launched a seven-day camp in this Taj Mahal...on sex and other licentious activities.// Ram...d, said he was opposed to sex education being give...vised the young to 'exercise restraint' rather tha...
... polluted river and a handful of concerned citizen...heralded World Earth Day Sunday, //by raising its ...ile ecosystem. 'We are on the brink of a cha... needs to be addressed immediately and a day such ...
...a massive immunization drive aimed at protecting m...eak. According to health experts, nearly 10% of th... Iraq's Ministry of Health is conducting the...ld Health Organization and UNICEF have got togethe...
... the US has sentenced a man to prison for conceali...to a plasma collection center at Hammond.// ...o selling blood contaminated with the HIV in Septe...a is the largest single component of blood, making...
...as combined nanotechnology and biology to enable t...rly results. Dr. Samuel is the director of the Ins...western University. He suggests that nanotechnolog...logy might achieve in regenerative medicine, paral...
Other Medicine News:Health News:High Melatonin can Help Delay Ageing 2Health News:Earth Day Celebrated With Hopes of a Greener Tomorrow 2Health News:Nanotechnology Could Treat Spinal Cord Injuries, Diabetes, and Parkinson's Disease 2
(Date:11/25/2009)...BRUNSWICK,N.J.,Nov.25/PRNewswire/--SwissrayInterna...ography( ddR )systems,announcedtodaythatitsoperati...gtermviewtowardsgrowingSwissray,smedicalimagingbra...roperty,aswellascontractsandinventory.After25years...xtleveloftechnologicaladvancementswithstableandste...
(Date:11/25/2009)...IEGO,Nov.25/PRNewswire-FirstCall/--NuVasive,Inc.(N...pingproductsforminimallydisruptivesurgicaltreatmen...ncecallonMonday,November30,2009,at5:30p.m.ET/2:30p...ativetoreimbursementfortheCompany,sproductsandwill...ionandanswersession.Thedial-innumbersare1-877-407-...
(Date:11/25/2009)...ORK,Nov.25/PRNewswire/--Reportlinker.comannouncest...ue: ,, PainManagement-GlobalTrends ,, h...t---Global-Trends.html ,, Widespreadavailabili...andtheadventofnewdrugshaveacceleratedthepaceofgrow...imbursementstructurecontinuetoshapedemandforservic...
Breaking Medicine Technology:Swissray International Announces New Ownership 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3Reportlinker Adds Pain Management - Global Trends 2Reportlinker Adds Pain Management - Global Trends 3Reportlinker Adds Pain Management - Global Trends 4Reportlinker Adds Pain Management - Global Trends 5Newly Updated Pharmacy State Law Compendium Available 5335 1Newly Updated Pharmacy State Law Compendium Available 5335 2Major health care challenges persist for D C children despite high rates of health insurance coverage RAND study finds 59154 1Major health care challenges persist for D C children despite high rates of health insurance coverage RAND study finds 59154 2Major health care challenges persist for D C children despite high rates of health insurance coverage RAND study finds 59154 3CSI in a virtual world 3A New grant furthers NC States work in forensic science 10303 1CSI in a virtual world 3A New grant furthers NC States work in forensic science 10303 2CSI in a virtual world 3A New grant furthers NC States work in forensic science 10303 3
... - Cytogen,Corporation (NASDAQ: CYTO) today announ...shed at upcoming major medical meetings. The,data ...QUADRAMET(R),(samarium Sm-153 lexidronam injection...astatic bone disease arising from prostate,cancer ...,evaluating the outcomes of prostate cancer patien...
...-- Once-daily,dosing with Otsuka,s investigational... antagonist, was associated with improvements,in s...ailure (ADHF),in hospitalized patients receiving c...ir long-term survival versus placebo.(1) These,dat...e,international landmark trial Efficacy of Vasopre...
Other Medicine Technology:New Clinical Data for Cytogen's Quadramet and Prostacint to be,Reported at Upcoming Major Medical Meetings 2New Clinical Data for Cytogen's Quadramet and Prostacint to be,Reported at Upcoming Major Medical Meetings 3New Clinical Data for Cytogen's Quadramet and Prostacint to be,Reported at Upcoming Major Medical Meetings 4New Clinical Data for Cytogen's Quadramet and Prostacint to be,Reported at Upcoming Major Medical Meetings 5Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 2Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 3Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 4Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 5Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 6Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 7
... Touch control panel with 3 charging wells. Availa...Blue and Cinnamon. Spring balanced refractor and s...ction for lifelong quality. Sealed hydraulic syste...ement. Chair back reclines manually to fully horiz...
...eveloped the patented HydroKeratome corneal cuttin...t and industry experts believe it will replace the...okeratome, currently used in the LASIK refractive ...Company has demonstrated that its proprietary tech...
2.5v Ophthalmoscope Set
3.5v Coaxial Ophthalmoscope Set
Medicine Products: